Literature DB >> 14675608

Snoring and excessive daytime sleepiness in Parkinson's disease.

Pedro Braga-Neto1, Francisco Pereira da Silva-Júnior, Francisca Sueli Monte, Pedro F C de Bruin, Veralice M S de Bruin.   

Abstract

Recent recognition of daytime sleepiness in Parkinson's disease (PD) has prompted a search for its causes. Sleepy patients may be more susceptible to sleep attacks after the use of dopamine agonists and the recognition of sleep disturbances in PD may influence important therapeutic decisions. To identify clinical factors influencing excessive daytime sleepiness (EDS) and sleep complaints in PD, we studied 86 consecutive patients with clinical diagnosis of PD using a sleep questionnaire, the Epworth Sleepiness Scale, the Unified Parkinson's Disease Rating Scale and the Montgomery and Asberg Depression Rating Scale. Patients with cognitive dysfunction were not included in the study. We found that 49 patients (53.3%) had insomnia, 45 (49.9%) restless legs syndrome (RLS), 51 (55.4%) vivid dreams, 61 (71.8%) snoring and 29 (31.5%) had EDS. RLS was more frequent in patients with longer duration of illness. Snoring was the most important risk factor associated with EDS (OR=3.64, 95% CI=1.11-11.9, P=0.03) and a marginal association between motor dysfunction and EDS was observed (OR=1.06, 95% CI=1.00-1.12, P=0.05).

Entities:  

Mesh:

Year:  2004        PMID: 14675608     DOI: 10.1016/j.jns.2003.08.010

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  23 in total

1.  Sleep in essential tremor: a comparison with normal controls and Parkinson's disease patients.

Authors:  Marina Gerbin; Amanda S Viner; Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2011-11-30       Impact factor: 4.891

2.  Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.

Authors:  Camila Andrade Mendes Medeiros; Pedro Felipe Carvalhedo de Bruin; Lívia Ariane Lopes; Maria Cecília Magalhães; Maria de Lourdes Seabra; Veralice Meireles Sales de Bruin
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

3.  Sleep disorders and daytime sleepiness in Parkinson's disease.

Authors:  Renee Monderer; Michael Thorpy
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

4.  Risk of sleep-disordered breathing in Parkinson's disease.

Authors:  Wattanachai Chotinaiwattarakul; Praveen Dayalu; Ronald D Chervin; Roger L Albin
Journal:  Sleep Breath       Date:  2010-05-16       Impact factor: 2.816

Review 5.  Epidemiology of Parkinson's disease.

Authors:  Guido Alves; Elin Bjelland Forsaa; Kenn Freddy Pedersen; Michaela Dreetz Gjerstad; Jan Petter Larsen
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

Review 6.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

7.  A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson's disease.

Authors:  Stefano Calzetti; Monica Angelini; Anna Negrotti; Elena Marchesi; Matteo Goldoni
Journal:  J Neural Transm (Vienna)       Date:  2013-12-20       Impact factor: 3.575

Review 8.  Parkinson's disease and sleep/wake disturbances.

Authors:  Keisuke Suzuki; Masayuki Miyamoto; Tomoyuki Miyamoto; Koichi Hirata
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

9.  Restless legs syndrome in multiple system atrophy.

Authors:  Imad Ghorayeb; Sandrine Dupouy; François Tison; Wassilios G Meissner
Journal:  J Neural Transm (Vienna)       Date:  2014-05-13       Impact factor: 3.575

10.  Effects of sleep disorders on the non-motor symptoms of Parkinson disease.

Authors:  Ariel B Neikrug; Jeanne E Maglione; Lianqi Liu; Loki Natarajan; Julie A Avanzino; Jody Corey-Bloom; Barton W Palmer; Jose S Loredo; Sonia Ancoli-Israel
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.